Clinical Trial Update: A Study Comparing the Effectiveness and Safety of Varying Dose Strengths (100, 200, 300 and 400 mg) of Extended-release Tramadol HCl With Placebo for the Treatment of Osteoarthritis(OA) of the Knee and/or Hip [Phase 3]

View source ↗

Summary

It summarizes a completed Phase 3 trial comparing multiple doses of extended-release tramadol hydrochloride with placebo for osteoarthritis of the knee and/or h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE (tramadol hydrochloride)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Chronic Pain | Phase 3 | Status: COMPLETED